[Procetofen, a new lipid- and urine-acid-reducing substance].
23 patients with different forms of hyperlipidemias received procetofen (3 X 100 mg/day) over a period of fourteen days. The cholesterol concentration in blood showed a significant reduction from 322 +/- 30 mg/dl to 227 +/- 37 mg/dl, triglycerides dropped from 221 +/- 84 mg/dl to 129 +/- 34 mg/dl and uric acid diminished from 6,1 +/- 1,4 mg/dl to 4,6 +/- 0,8 mg/dl.
D002784:Cholesterol / Q000097:blood; D003864:Depression, Chemical; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D011422:Propionates / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood*
D000960:Hypolipidemic Agents; D011422:Propionates; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol
Procetofen, eine neue Lipid- und Harnsäure-senkende Substanz.